Raffles Medical Group Ltd

Informe acción SGX:BSL

Capitalización de mercado: S$1.9b

Dividendos de Raffles Medical Group

Dividendo controles de criterios 3/6

Raffles Medical Group es una empresa que paga dividendos con una rentabilidad actual de 2.38% que está bien cubierta por los beneficios. La próxima fecha de pago es en 23rd May, 2024 con una fecha ex dividendo de 13th May, 2024.

Información clave

2.4%

Rentabilidad por dividendo

50%

Ratio de pago

Rentabilidad media de la industria2.5%
Próxima fecha de pago de dividendos23 May 24
Fecha ex dividendo13 May 24
Dividendo por acciónn/a
Beneficios por acciónS$0.049
Rentabilidad por dividendo prevista a 3 años2.2%

Últimas actualizaciones de dividendos

Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Apr 25
Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038

May 01
Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038

Recent updates

Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Apr 25
Raffles Medical Group's (SGX:BSL) Dividend Is Being Reduced To SGD0.024

Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Apr 10
Raffles Medical Group's (SGX:BSL) Sluggish Earnings Might Be Just The Beginning Of Its Problems

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Nov 16
Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Nov 03
Raffles Medical Group (SGX:BSL) Is Doing The Right Things To Multiply Its Share Price

Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors

Aug 23
Here's Why Raffles Medical Group (SGX:BSL) Has Caught The Eye Of Investors

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Jul 24
The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt

Jun 13
Raffles Medical Group (SGX:BSL) Could Easily Take On More Debt

A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)

May 30
A Look At The Fair Value Of Raffles Medical Group Ltd (SGX:BSL)

Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?

May 12
Is Now The Time To Put Raffles Medical Group (SGX:BSL) On Your Watchlist?

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038

May 01
Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To SGD0.038

Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger

Mar 13
Raffles Medical Group (SGX:BSL) Might Have The Makings Of A Multi-Bagger

Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Feb 14
Estimating The Intrinsic Value Of Raffles Medical Group Ltd (SGX:BSL)

Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up

Dec 04
Returns At Raffles Medical Group (SGX:BSL) Are On The Way Up

Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?

Nov 21
Do Raffles Medical Group's (SGX:BSL) Earnings Warrant Your Attention?

Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Oct 09
Is There An Opportunity With Raffles Medical Group Ltd's (SGX:BSL) 25% Undervaluation?

Is Raffles Medical Group (SGX:BSL) A Risky Investment?

Sep 26
Is Raffles Medical Group (SGX:BSL) A Risky Investment?

The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

Sep 01
The Return Trends At Raffles Medical Group (SGX:BSL) Look Promising

With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Aug 20
With EPS Growth And More, Raffles Medical Group (SGX:BSL) Makes An Interesting Case

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Jun 01
Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028

May 02
Raffles Medical Group (SGX:BSL) Is Increasing Its Dividend To S$0.028

We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease

Apr 18
We Think Raffles Medical Group (SGX:BSL) Can Manage Its Debt With Ease

Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement

Feb 21
Slowing Rates Of Return At Raffles Medical Group (SGX:BSL) Leave Little Room For Excitement

Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly

Oct 14
Raffles Medical Group (SGX:BSL) Seems To Use Debt Rather Sparingly

Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

Oct 02
Raffles Medical Group (SGX:BSL) Has Some Way To Go To Become A Multi-Bagger

At S$1.40, Is Raffles Medical Group Ltd (SGX:BSL) Worth Looking At Closely?

Sep 21
At S$1.40, Is Raffles Medical Group Ltd (SGX:BSL) Worth Looking At Closely?

Here's Why I Think Raffles Medical Group (SGX:BSL) Is An Interesting Stock

Aug 12
Here's Why I Think Raffles Medical Group (SGX:BSL) Is An Interesting Stock

Here's What's Concerning About Raffles Medical Group's (SGX:BSL) Returns On Capital

Jul 01
Here's What's Concerning About Raffles Medical Group's (SGX:BSL) Returns On Capital

At S$1.08, Is It Time To Put Raffles Medical Group Ltd (SGX:BSL) On Your Watch List?

May 25
At S$1.08, Is It Time To Put Raffles Medical Group Ltd (SGX:BSL) On Your Watch List?

Does This Valuation Of Raffles Medical Group Ltd (SGX:BSL) Imply Investors Are Overpaying?

Apr 05
Does This Valuation Of Raffles Medical Group Ltd (SGX:BSL) Imply Investors Are Overpaying?

Returns On Capital At Raffles Medical Group (SGX:BSL) Paint A Concerning Picture

Mar 24
Returns On Capital At Raffles Medical Group (SGX:BSL) Paint A Concerning Picture

Is Raffles Medical Group (SGX:BSL) Using Too Much Debt?

Mar 12
Is Raffles Medical Group (SGX:BSL) Using Too Much Debt?

Robust Earnings May Not Tell The Whole Story For Raffles Medical Group (SGX:BSL)

Feb 28
Robust Earnings May Not Tell The Whole Story For Raffles Medical Group (SGX:BSL)

Insider Buying: The Raffles Medical Group Ltd (SGX:BSL) Executive Chairman & CEO Just Bought S$1.5m Worth Of Shares

Feb 24
Insider Buying: The Raffles Medical Group Ltd (SGX:BSL) Executive Chairman & CEO Just Bought S$1.5m Worth Of Shares

What Is Raffles Medical Group Ltd's (SGX:BSL) Share Price Doing?

Feb 22
What Is Raffles Medical Group Ltd's (SGX:BSL) Share Price Doing?

Próximo pago de dividendos

HoyApr 26 2024Fecha ex dividendoMay 13 2024Fecha de pago de dividendosMay 23 202410 days desde ex dividendoCompra en los próximos 16 days para recibir el próximo dividendo

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: El pago de dividendos de BSL ha sido volátil en los últimos 10 años.

Dividendo creciente: El pago de dividendos de BSL ha aumentado en los últimos 10 años.


Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Raffles Medical Group vs. Mercado
¿Cómo se compara la rentabilidad por dividendo de BSL con la del mercado?
SegmentoRentabilidad por dividendo
Empresa (BSL)2.4%
Suelo de mercado 25% (SG)2.8%
Techo de mercado 25% (SG)6.3%
Media de la industria (Healthcare)2.5%
Previsión de analistas en 3 años (BSL)2.2%

Dividendo destacado: El dividendo de BSL(2.38%) no es notable en comparación con el 25% inferior de pagadores de dividendos del mercado SG (2.8%).

Alto dividendo: El (2.35%) del dividendo de BSL es bajo en comparación con el 25% de los principales pagadores de dividendos del mercado SG (6.29%).


Pago de beneficios a los accionistas

Cobertura de los beneficios: Con su razonablemente bajo ratio de pago (49.5%), los pagos de dividendos de BSL están bien cubiertos por los beneficios.


Pago en efectivo a los accionistas

Cobertura de flujo de caja: Con su razonablemente bajo ratio de pago en efectivo (26.6%), los pagos de dividendos de BSL están bien cubiertos por los flujos de caja.


Discover strong dividend paying companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target